英国药品和医疗产品监管署批准辉瑞/BioNTech的二价新冠加强针

array(1) { [433598]=> array(2) { [2]=> array(4) { [0]=> string(6) "英国" [1]=> string(6) "药品" [2]=> string(6) "辉瑞" [3]=> string(12) "新冠疫情" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }